StockData
Akebia Therapeutics, Inc. logo

Akebia Therapeutics, Inc. (AKBA) stock

AKBANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.41+0.01 (+2.12%)

Close on Nov 18, 2026Market cap $113.31MP/E –Yield –

Akebia Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Akebia Therapeutics's EV/EBITDA was 45.4× on Jul 31, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202645.4×+28.1
2025Dec 31, 202517.3×–

More Akebia Therapeutics figures

See a number that looks wrong?